Please find all related articles below.
As the European Commission undertakes its evaluation of the expiring Action Plan on Antimicrobial Resistance (AMR), the joint EPHA - Health Care Without Harm Europe (HCWH) event of 10 December called for a much stronger consideration of the environmental dimension of AMR. A detailed event report is now available.
The event was hosted by MEPs Martin Häusling (Greens, Germany) and Jasenko Selimovic (ALDE, SWE). Both MEPs underlined the need for urgent action, with MEP Selimovic concluding (...)
On 10 February 2016, European Ministers of Health and Agriculture were invited by the Netherlands Presidency of the EU Council to a Ministerial Conference on Antimicrobial Resistance (AMR) in Amsterdam. The Ministers discussed the scale and urgency of the crisis facing health systems around the world. For the fight against AMR to be successful, the most important element is coordinated international action, not least at the EU level. Dutch Minister of Agriculture Martijn van Dam made it (...)
Representatives of the pharmaceutical industry have responded to letters sent by EPHA and partners urging the industry to make their global supply chains transparent and adopt environmentally responsible management practices. While a number of initiatives are being supported by industry, the problem remains that these are non-binding and fragmented. As manufacturers and suppliers, and nodes in a multi-billion industry, pharma companies must do more and push for mandatory standards and (...)
Partners of the ENS4Care project presented the final guidelines for the deployment of eHealth by nurses and social workers to policymakers on 8 December 2015 in the context of the European Innovation Summit,. The acceptance of eHealth by health and social care professionals is fundamental in order for it to be taken up successfully across Europe.
The project - ENS4Care
Over the last two years, the partners of the ENS4Care project, which also includes EPHA, have developed eHealth (...)
On 10 December 2015, EPHA and Health Care Without Harm Europe organised an event that discussed the link between AMR and environmental pollution, focusing on antibiotics manufacturing and animal husbandry. The event established that all stakeholders - in particular industry and regulators - must push for enforceable standards and regulation. A new EPHA report further develops this theme.
Why is the environment neglected in AMR debates?
Despite a number of scandals and growing evidence (...)
eHealth, mobile apps and digital medical services are sparking many hopes and concerns at the same time. The #Datacare debate held on 15 September 2015 at the European Parliament specifically explored the question, “What can data driven healthcare do for Europe?”
In our globalised, digital world, things are changing rapidly and technology is an inevitable, driving feature of innovation. In the future, health systems are likely to be permeated more and more by technology. Now is (...)
Supplying poor and developing countries with medicines at sustainable, reduced prices is one of the most important tools in the fight against major diseases, especially the “Big Three”, namely HIV, TB and malaria. After more than a decade since the Council Regulation (EC) 953/2003 came into force, to avoid trade diversion into the European Union of certain key medicines, stakeholders came together to discuss the overall impact of the Regulation at a workshop on 15 July 2015, (...)
Public health is not just about human diseases, healthcare services or cross-border pandemics. Most of all, health is about people. Giving wider attention to the individual also fits perfectly with the European 2020 vision of ’smart, inclusive and sustainable’ growth for a healthier EU, as highlighted at a recent meeting on ’health literacy in Europe’ organised by STOA - European Parliament Science and Technology Options Assessment - on 1 July 2015.
People are used (...)
An event organised by the CEPS on 13 May 2015 provided an update of the status quo of the General Data Protection Regulation (GDPR) and presented issues under discussion during the Trilogue negotiations. Although the principal focus lay on stimulating dialogue between regulators and SMEs/start-ups, the debate also touched upon some health-related issues such as the development of eHealth as part of the Digital Single Market, and it brought up ethical questions related to the potential uses (...)
Unsurprisingly, mHealth was a hotly debated topic during the 2015 eHealth Week hosted by the Latvian Council Presidency. In addition to the official conference programme, where the mHealth summit uncovered some of the latest developments in this area, the European Commission also organised a stakeholder meeting including industry and civil society representatives to determine the appropriate level of regulation for mHealth at EU level.
European Health Commissioner Vytenis Andriukaitis (...)